Advanced Micro Devices vs. Broadcom: Which Semiconductor Stock Is a Better Buy in 2026?

The comparison favors Broadcom over AMD for 2026, citing Broadcom’s lower forward P/E of 30.4x versus AMD’s 83.1x and its 2025 revenue of $63.9B and net income of $23.1B. Analysts cited in the article expect Broadcom revenue to rise 66% to $106B this year, while AMD is expected to post $49.6B in sales, up more than 40%, and $8.7B in net income. Both companies benefit from AI-chip demand but face customer concentration and other risks; the article concludes Broadcom offers the better valuation relative to growth.

Analysis

The comparison supports a relative-value question, not a clean “safer stock” conclusion. AVGO’s lower stated forward multiple only matters if the projected acceleration converts into shipped custom silicon and networking revenue; concentrated hyperscaler demand and reliance on TSMC can make that earnings base more cyclical than the software mix suggests. Conversely, AMD’s premium embeds substantial execution: an announced customer opportunity is not equivalent to committed, profitable shipments, and competitive displacement of NVDA is not established by the figures provided.

The key near-term risk is estimate quality. The article mixes fiscal periods and forward estimates, and its dates and projections should be checked against current filings and guidance before trading; treat the quoted valuations and growth forecasts as unverified inputs. Over 1–3 months, monitor actual AI-related revenue, customer commitments converted to shipments, gross-margin trajectory, and estimate revisions. Over 6–18 months, custom accelerators could broaden AVGO’s addressable demand while intensifying customer bargaining power; AMD’s upside depends on product competitiveness, software adoption, and repeat orders. TSMC is a common supply-chain exposure, so owning both names does not diversify that risk. The contrarian risk to a simple AVGO-over-AMD view is that AMD’s premium can persist or expand if deployments materially outperform expectations, while AVGO’s apparently cheaper multiple may prove less attractive if hyperscaler projects slip or software retention weakens.

Key Decisions for Investors

• Do not trade the article’s headline valuation comparison until its fiscal-period data, current prices, consensus estimates, and forward multiples are verified. Treat any unverified growth forecast as a watch item, not a base case.
• If verified estimates still show a pronounced valuation gap, consider a small beta-adjusted long AVGO / short AMD relative-value position after the next earnings or guidance update. The thesis is multiple convergence through AVGO estimate delivery—not that AVGO is low risk. Keep gross exposure modest because both names share AI-capex and TSMC supply-chain sensitivities.
• For the pair, add only if AVGO reports shipment or revenue conversion consistent with its AI outlook and margins hold; reduce or exit if custom-chip ramps are delayed, hyperscaler spending guidance weakens, or VMware-related retention/regulatory developments impair the software contribution. A sharp upward AMD estimate-revision cycle or evidence of repeat, profitable GPU orders falsifies the short leg.
• Avoid an outright AMD short solely on valuation: the potential upside from successful deployments is asymmetric and difficult to quantify from the article. Reassess after disclosures specify order timing, shipment volumes, and economics.